Recruiting
Phase 3

Olanzapine vs. Megestrol Acetate

Sponsor:

Alliance for Clinical Trials in Oncology

Code:

NCT04939090

Conditions

Advanced Malignant Solid Neoplasm

Anorexia

Hematopoietic and Lymphoid Cell Neoplasm

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Olanzapine

Megestrol Acetate

Questionnaire Administration

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-09-14. This information was provided to ClinicalTrials.gov by Alliance for Clinical Trials in Oncology on 2025-09-08.